Projects per year
Personal profile
Campus career
和漢医薬学総合研究所 准教授 2012/04/01-2017/03/31
和漢医薬学総合研究所 教授 2017/04/01-2019/09/30
薬学・和漢系 教授 2019/10/01-
和漢医薬学総合研究所 教授 2019/10/01-
和漢医薬学総合研究所 教授 2017/04/01-2019/09/30
薬学・和漢系 教授 2019/10/01-
和漢医薬学総合研究所 教授 2019/10/01-
Research interests
病態における自然免疫応答の役割解明と創薬への応用
1)NK細胞のバイオロジーと腫瘍免疫応答における役割
2)がん病態進展における腫瘍微小環境での自然免疫応答の役割
3)がんモデルにおける病態のリアルタイムイメージング
4) 和漢薬による免疫疾患制御
1)NK細胞のバイオロジーと腫瘍免疫応答における役割
2)がん病態進展における腫瘍微小環境での自然免疫応答の役割
3)がんモデルにおける病態のリアルタイムイメージング
4) 和漢薬による免疫疾患制御
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research Fields, Keywords
- Cancer
- Immunology
- Inflammation
- metastasis
- Host defenses
- Natural Killer cell
Field of expertise (Grants-in-aid for Scientific Research classification)
- Oncology
Fingerprint
Dive into the research topics where Yoshihiro Hayakawa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
NK細胞の腫瘍組織内での疲弊プロセスの解明
Hayakawa, Y. (Principal Investigator)
Japan Society for the Promotion of Science
2025/04/01 → 2028/03/31
Project: Research Project
-
SOX10 regulates melanoma heterogeneity
Yokoyama, S. (Principal Investigator), Hayakawa, Y. (Co-Investigator(Kenkyū-buntansha)) & Hayashi, R. (Co-Investigator(Kenkyū-buntansha))
Japan Society for the Promotion of Science
2024/04/01 → 2027/03/31
Project: Research Project
-
-
-
帯電性ナノバブルによる胸膜播種抑制効果の研究
崇浩本間 (Principal Investigator), 大平猛 (Co-Investigator(Kenkyū-buntansha)), Hayakawa, Y. (Co-Investigator(Kenkyū-buntansha)), Sasaki, S. (Co-Investigator(Kenkyū-buntansha)) & Susukida, T. (Co-Investigator(Kenkyū-buntansha))
Japan Society for the Promotion of Science
2022/04/01 → 2025/03/31
Project: Research Project
-
Characterization of anti-asialo-GM1 monoclonal antibody
He, K., Kimura, T., Takeda, K. & Hayakawa, Y., 2025/01, In: Biochemical and Biophysical Research Communications. 743, 151197.Research output: Contribution to journal › Article › peer-review
Open Access -
CAMSAP2 enhances lung cancer cell metastasis by mediating RASAL2 degradation
Singharajkomron, N., Yodsurang, V., Limprasutr, V., Wattanathamsan, O., Iksen, I., Hayakawa, Y. & Pongrakhananon, V., 2024/02/01, In: Life Sciences. 338, 122391.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
CAMSAP3-mediated regulation of HMGB1 acetylation and subcellular localization in lung cancer cells: Implications for cell death modulation
Singharajkomron, N., Seephan, S., Iksen, I., Chantaravisoot, N., Wongkongkathep, P., Hayakawa, Y. & Pongrakhananon, V., 2024/06, In: BBA - General Subjects. 1868, 6, 130614.Research output: Contribution to journal › Article › peer-review
-
Correction to: IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting (Nature Communications, (2017), 8, 1, (14607), 10.1038/ncomms14607)
Takeda, K., Nakayama, M., Hayakawa, Y., Kojima, Y., Ikeda, H., Imai, N., Ogasawara, K., Okumura, K., Thomas, D. M. & Smyth, M. J., 2024/12, In: Nature Communications. 15, 1, 10558.Research output: Contribution to journal › Comment/debate
Open Access -
Corrigendum to “CAMSAP3-mediated regulation of HMGB1 acetylation and subcellular localization in lung cancer cells: Implications for cell death modulation”. [BBA - General Subjects (2024) 1868: 130614] (BBA - General Subjects (2024) 1868(6), (S0304416524000576), (10.1016/j.bbagen.2024.130614))
Singharajkomron, N., Seephan, S., Iksen, I., Chantaravisoot, N., Wongkongkathep, P., Hayakawa, Y. & Pongrakhananon, V., 2024/08, In: BBA - General Subjects. 1868, 8, 130644.Research output: Contribution to journal › Comment/debate
Datasets
-
Additional file 2 of Anti-inflammatory effects of Morus alba Linne bark on the activation of toll-like receptors and imiquimod-induced ear edema in mice
Umeyama, L. (Creator), Hardianti, B. (Contributor), Kasahara, S. (Creator), Dibwe, D. F. (Contributor), Awale, S. (Creator), Yokoyama, S. (Creator) & Hayakawa, Y. (Creator), figshare, 2021
DOI: 10.6084/m9.figshare.14396845, https://springernature.figshare.com/articles/presentation/Additional_file_2_of_Anti-inflammatory_effects_of_Morus_alba_Linne_bark_on_the_activation_of_toll-like_receptors_and_imiquimod-induced_ear_edema_in_mice/14396845
Dataset
-
Anti-inflammatory effects of Morus alba Linne bark on the activation of toll-like receptors and imiquimod-induced ear edema in mice
Umeyama, L. (Creator), Hardianti, B. (Contributor), Kasahara, S. (Creator), Dibwe, D. F. (Contributor), Awale, S. (Creator), Yokoyama, S. (Creator) & Hayakawa, Y. (Creator), figshare, 2021
DOI: 10.6084/m9.figshare.c.5371306.v1, https://springernature.figshare.com/collections/Anti-inflammatory_effects_of_Morus_alba_Linne_bark_on_the_activation_of_toll-like_receptors_and_imiquimod-induced_ear_edema_in_mice/5371306/1
Dataset
-
Additional file 2 of Anti-inflammatory effects of Morus alba Linne bark on the activation of toll-like receptors and imiquimod-induced ear edema in mice
Umeyama, L. (Creator), Hardianti, B. (Contributor), Kasahara, S. (Creator), Dibwe, D. F. (Contributor), Awale, S. (Creator), Yokoyama, S. (Creator) & Hayakawa, Y. (Creator), figshare, 2021
DOI: 10.6084/m9.figshare.14396845.v1, https://springernature.figshare.com/articles/presentation/Additional_file_2_of_Anti-inflammatory_effects_of_Morus_alba_Linne_bark_on_the_activation_of_toll-like_receptors_and_imiquimod-induced_ear_edema_in_mice/14396845/1
Dataset
-
SARS-CoV-2 spike RBD in complex with neutralizing antibody UT28K
Ozawa, T. (Contributor), Tani, H. (Contributor), Anraku, Y. (Contributor), Kita, S. (Contributor), Igarashi, E. (Contributor), Saga, Y. (Contributor), Inasaki, N. (Contributor), Kawasuji, H. (Contributor), Yamada, H. (Contributor), Sasaki, S.-I. (Contributor), Somekawa, M. (Contributor), Sasaki, J. (Contributor), Hayakawa, Y. (Contributor), Yamamoto, Y. (Contributor), Morinaga, Y. (Contributor), Kurosawa, N. (Contributor), Isobe, M. (Contributor), Fukuhara, H. (Contributor), Maenaka, K. (Contributor), Hashiguchi, T. (Contributor), Kishi, H. (Contributor), Kitajima, I. (Contributor), Saito, S. (Contributor) & Niimi, H. (Contributor), Protein Data Bank (PDB), 2022/05/25
DOI: 10.2210/pdb7X7O/pdb, https://www.wwpdb.org/pdb?id=pdb_00007x7o
Dataset
-
Anti-inflammatory effects of Morus alba Linne bark on the activation of toll-like receptors and imiquimod-induced ear edema in mice
Umeyama, L. (Creator), Hardianti, B. (Contributor), Kasahara, S. (Creator), Dibwe, D. F. (Contributor), Awale, S. (Creator), Yokoyama, S. (Creator) & Hayakawa, Y. (Creator), figshare, 2021
DOI: 10.6084/m9.figshare.c.5371306, https://springernature.figshare.com/collections/Anti-inflammatory_effects_of_Morus_alba_Linne_bark_on_the_activation_of_toll-like_receptors_and_imiquimod-induced_ear_edema_in_mice/5371306
Dataset
Prizes
Activities
- 27 Oral presentation
-
Role of inflammatory microenvironment for acquiring malignant phenotypes in QR32 fibrosarcoma model
Hayakawa, Y. (Speaker)
2013/10/03 → 2013/10/05Activity: Talk or presentation › Oral presentation
-
Mesenchymal-transitioned cancer cells instigate surrounding cancer cells to metastasis via secretion of WNT ligands
Hayakawa, Y. (Speaker)
2013/10/03 → 2013/10/05Activity: Talk or presentation › Oral presentation
-
Role of cross- talk between host immune responses and cancer cells in metastasis disease
Hayakawa, Y. (Speaker)
2013/10/03 → 2013/10/05Activity: Talk or presentation › Oral presentation
-
Resveratrol induces apoptosis in melanoma cells via downregulation of survivin expression.
Hayakawa, Y. (Speaker)
2013/10/03 → 2013/10/05Activity: Talk or presentation › Oral presentation
-
Cross-talk between host and cancer cells amplify inflammation triggered by gdT17 cells to promote malignant progression.
Hayakawa, Y. (Speaker)
2013/10/03 → 2013/10/05Activity: Talk or presentation › Oral presentation
Courses
-
応用和漢医薬学特論
Watanabe, S., Tohda, C., Morita, H., Hayakawa, Y., Awale, S., Nakagawa, Y., Kim, J. & Oku, M. 2024/12/04 → 2025/03/31
Course
-
医薬品薬効動態学実習
Hosoya, K.-I., Tabuchi, A., Nitta, A., Sasaoka, T., Hashimoto, Y., To, H., Akanuma, S.-I., So, T., Kume, T., Sakurai, H., Watanabe, S., Shibahara, N., Tohda, C., Koizumi, K., Hayakawa, Y., Nakagawa, Y. & Kim, J. 2024/10/01 → 2025/03/31
Course
-
医薬品薬効動態学実習
Hosoya, K.-I., Tabuchi, A., Nitta, A., Sasaoka, T., Hashimoto, Y., To, H., Akanuma, S.-I., So, T., Kume, T., Sakurai, H., Watanabe, S., Shibahara, N., Tohda, C., Koizumi, K., Hayakawa, Y., Nakagawa, Y. & Kim, J. 2024/10/01 → 2025/03/31
Course
-
国際医薬学特論
Hosoya, K.-I., Tomohiro, T., Sakai, H., Tabuchi, A., Hirose, Y., Nitta, A., Matsuya, Y., Shimizu, T., Chiba, J., Fujii, T., Kume, T., Tohda, C., Koizumi, K., Morita, H., Hayakawa, Y., Awale, S. & Nakagawa, Y. 2024/10/01 → 2025/03/31
Course
-
国際医薬学特論
Hosoya, K.-I., Tomohiro, T., Sakai, H., Tabuchi, A., Hirose, Y., Nitta, A., Matsuya, Y., Shimizu, T., Chiba, J., Fujii, T., Kume, T., Tohda, C., Koizumi, K., Morita, H., Hayakawa, Y., Awale, S. & Nakagawa, Y. 2024/10/01 → 2025/03/31
Course